Open AccessClinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis
Author(s) -
AnnMarie Powell,
Khalil G. Ghanem,
Linda C. Rogers,
Ashley Zinalabedini,
Rebecca M. Brotman,
Jonathan M. Zenilman,
Susan Tuddenham
Publication year - 2019
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0000000000001063
Subject(s) - bacterial vaginosis , medicine , boric acid , vulvovaginal candidiasis , maintenance therapy , adverse effect , vaginal disease , obstetrics , vagina , dermatology , surgery , chemotherapy , antifungal , physics , nuclear physics
A retrospective chart review characterized clinicians' use of maintenance intravaginal boric acid for women with recurrent vulvovaginal candidiasis or bacterial vaginosis. Average length of use was 13 months with high patient satisfaction and few adverse events. Prospective studies are needed to evaluate the efficacy of maintenance boric acid for these conditions.